UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 28, 2015
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission File Number: 001-36743
Apple Inc.
(Exact name of Registrant as specified in its charter)
California
94-2404110
(State or other jurisdiction
of incorporation or organization)
(I.R.S. Employer Identification No.)
1 Infinite Loop
Cupertino, California
95014
(Address of principal executive offices)
(Zip Code)
(408) 996-1010
(Registrant s telephone number, including area code)
Indicate by check mark whether
the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days.
Yes No
Indicate by check mark whether the Registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File
required to be submitted and posted pursuant to Rule 405 of Regulation S-T ( 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit and post such files).
Yes No
Indicate by check mark whether the Registrant is
a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule
12b-2 of the Exchange Act.
Large accelerated filer
Accelerated filer
Non-accelerated filer
(Do not check if a smaller reporting company)
Smaller reporting company
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes No
5,761,030,000 shares of common stock, par value $0.00001
per share, issued and outstanding as of April 10, 2015
Table of Contents
Apple Inc.
Form 10-Q
For the Fiscal Quarter Ended
March 28, 2015
TABLE OF CONTENTS
Page
Part I
Item 1.
Financial Statements
Item 2.
Management s Discussion and Analysis of Financial Condition and Results of Operations
23
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
36
Item 4.
Controls and Procedures
37
Part II
Item 1.
Legal Proceedings
38
Item 1A.
Risk Factors
39
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
49
Item 3.
Defaults Upon Senior Securities
49
Item 4.
Mine Safety Disclosures
49
Item 5.
Other Information
49
Item 6.
Exhibits
50
Table of Contents
PART I FINANCIAL INFORMATION
Item 1.
Financial Statements
Apple Inc.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
(In millions, except number of shares which are reflected in thousands and per share amounts)
Three Months Ended
Six Months Ended
March 28,
2015
March 29,
2014
March 28,
2015
March 29,
2014
Net sales
58,010
45,646
132,609
103,240
Cost of sales
34,354
27,699
79,212
63,447
Gross margin
23,656
17,947
53,397
39,793
Operating expenses:
Research and development
1,918
1,422
3,813
2,752
Selling, general and administrative
3,460
2,932
7,060
5,985
Total operating expenses
5,378
4,354
10,873
8,737
Operating income
18,278
13,593
42,524
31,056
Other income/(expense), net
286
225
456
471
Income before provision for income taxes
18,564
13,818
42,980
31,527
Provision for income taxes
4,995
3,595
11,387
8,232
Net income
13,569
10,223
31,593
23,295
Earnings per share:
Basic
2.34
1.67
5.43
3.76
Diluted
2.33
1.66
5.39
3.74
Shares used in computing earnings per share:
Basic
5,793,799
6,123,302
5,818,441
6,197,903
Diluted
5,834,858
6,156,699
5,858,330
6,233,430
Cash dividends declared per share
0.47
0.44
0.94
0.88
See accompanying Notes to Condensed Consolidated Financial Statements.
Table of Contents
Apple Inc.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)
(In millions)
Three Months Ended
Six Months Ended
March 28,
2015
March 29,
2014
March 28,
2015
March 29,
2014
Net income
13,569
10,223
31,593
23,295
Other comprehensive income:
Change in foreign currency translation, net of tax
(180
(19
(246
(86
Change in unrealized gains/losses on derivative instruments:
Change in fair value of derivatives, net of tax
1,037
(109
3,019
104
Adjustment for net (gains)/losses realized and included in net income, net of tax
(739
(13
(1,304
59
Total change in unrealized gains/losses on derivative instruments, net of tax
298
(122
1,715
163
Change in unrealized gains/losses on marketable securities:
Change in fair value of marketable securities, net of tax
593
235
137
193
Adjustment for net (gains)/losses realized and included in net income, net of tax
36
(39
22
(50
Total change in unrealized gains/losses on marketable securities, net of tax
629
196
159
143
Total other comprehensive income
747
55
1,628
220
Total comprehensive income
14,316
10,278
33,221
23,515
See accompanying Notes to Condensed Consolidated Financial Statements.
Table of Contents
Apple Inc.
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
(In millions, except number of shares which are reflected in thousands and par value)
March 28,
2015
September 27,
2014
ASSETS:
Current assets:
Cash and cash equivalents
14,489
13,844
Short-term marketable securities
18,607
11,233
Accounts receivable, less allowances of $83 and $86, respectively
10,905
17,460
Inventories
2,396
2,111
Deferred tax assets
5,141
4,318
Vendor non-trade receivables
7,259
9,759
Other current assets
9,094
9,806
Total current assets
67,891
68,531
Long-term marketable securities
160,443
130,162
Property, plant and equipment, net
20,151
20,624
Goodwill
4,711
4,616
Acquired intangible assets, net
4,061
4,142
Other assets
3,937
3,764
Total assets
261,194
231,839
LIABILITIES AND SHAREHOLDERS EQUITY:
Current liabilities:
Accounts payable
23,159
30,196
Accrued expenses
22,827
18,453
Deferred revenue
8,944
8,491
Commercial paper
3,799
6,308
Total current liabilities
58,729
63,448
Deferred revenue non-current
3,571
3,031
Long-term debt
40,072
28,987
Other non-current liabilities
29,816
24,826
Total liabilities
132,188
120,292
Commitments and contingencies
Shareholders equity:
Common stock and additional paid-in capital, $0.00001 par value: 12,600,000 shares authorized; 5,762,278 and 5,866,161 shares issued and
outstanding, respectively
25,376
23,313
Retained earnings
100,920
87,152
Accumulated other comprehensive income
2,710
1,082
Total shareholders equity
129,006
111,547
Total liabilities and shareholders equity
261,194
231,839
See accompanying Notes to Condensed Consolidated Financial Statements.
Table of Contents
Apple Inc.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
(In millions)
Six Months Ended
March 28,
2015
March 29,
2014
Cash and cash equivalents, beginning of the period
13,844
14,259
Operating activities:
Net income
31,593
23,295
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
5,054
4,031
Share-based compensation expense
1,815
1,377
Deferred income tax expense
1,879
2,059
Changes in operating assets and liabilities:
Accounts receivable, net
6,555
3,401
Inventories
(285
(65
Vendor non-trade receivables
2,500
1,419
Other current and non-current assets
2,448
14
Accounts payable
(5,428
(2,375
Deferred revenue
993
1,414
Other current and non-current liabilities
5,679
1,638
Cash generated by operating activities
52,803
36,208
Investing activities:
Purchases of marketable securities
(92,523
(90,360
Proceeds from maturities of marketable securities
5,871
10,869
Proceeds from sales of marketable securities
48,924
80,241
Payments made in connection with business acquisitions, net
(115
(559
Payments for acquisition of property, plant and equipment
(5,586
(3,367
Payments for acquisition of intangible assets
(155
(163
Other
88
(23
Cash used in investing activities
(43,496
(3,362
Financing activities:
Proceeds from issuance of common stock
309
341
Excess tax benefits from equity awards
357
363
Taxes paid related to net share settlement of equity awards
(608
(430
Dividends and dividend equivalents paid
(5,544
(5,430
Repurchase of common stock
(12,000
(23,000
Proceeds from issuance of long-term debt, net
11,332
Repayments of commercial paper, net
(2,508
Cash used in financing activities
(8,662
(28,156
Increase in cash and cash equivalents
645
4,690
Cash and cash equivalents, end of the period
14,489
18,949
Supplemental cash flow disclosure:
Cash paid for income taxes, net
7,058
5,369
Cash paid for interest
220
161
See accompanying Notes to Condensed Consolidated Financial Statements.
Table of Contents
Apple Inc.
Notes to Condensed Consolidated Financial Statements (Unaudited)
Note 1 Summary of Significant Accounting Policies
Apple Inc. and its wholly-owned subsidiaries (collectively Apple or the Company ) designs, manufactures and
markets mobile communication and media devices, personal computers and portable digital music players, and sells a variety of related software, services, accessories, networking solutions and third-party digital content and applications. The Company
sells its products worldwide through its retail stores, online stores and direct sales force, as well as through third-party cellular network carriers, wholesalers, retailers and value-added resellers. In addition, the Company sells a variety of
third-party iPhone, iPad, Mac and iPod compatible products, including application software, and various accessories through its online and retail stores. The Company sells to consumers, small and mid-sized businesses and education, enterprise and
government customers.
Basis of Presentation and Preparation
The accompanying condensed consolidated financial statements include the accounts of the Company. Intercompany accounts and transactions have been
eliminated. The preparation of these condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles ( GAAP ) requires management to make estimates and assumptions that affect the amounts
reported in these condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates.
These condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company s annual consolidated
financial statements and the notes thereto for the fiscal year ended September 27, 2014, included in its Annual Report on Form 10-K as updated by the Company s Current Report on Form 8-K dated January 28, 2015 (hereinafter, the
2014 Form 10-K ). The Company s fiscal year is the 52 or 53-week period that ends on the last Saturday of September. An additional week is included in the first fiscal quarter approximately every six years to realign fiscal quarters
with calendar quarters. The Company s fiscal years 2015 and 2014 each include 52 weeks. Unless otherwise stated, references to particular years, quarters or months refer to the Company s fiscal years ended in September and the associated
quarters or months of those fiscal years.
Earnings Per Share
Basic earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock
outstanding during the period. Diluted earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period increased to include the number of
additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding stock options, shares to be purchased under the Company s employee
stock purchase plan, unvested restricted stock and unvested restricted stock units ( RSUs ). The dilutive effect of potentially dilutive securities is reflected in diluted earnings per share by application of the treasury stock method.
Under the treasury stock method, an increase in the fair market value of the Company s common stock can result in a greater dilutive effect from potentially dilutive securities.
The following table shows the computation of basic and diluted earnings per share for the three- and six-month periods ended March 28, 2015 and
March 29, 2014 (net income in millions and shares in thousands):
Three Months Ended
Six Months Ended
March 28,
2015
March 29,
2014
March 28,
2015
March 29,
2014
Numerator:
Net income
13,569
10,223
31,593
23,295
Denominator:
Weighted-average shares outstanding
5,793,799
6,123,302
5,818,441
6,197,903
Effect of dilutive securities
41,059
33,397
39,889
35,527
Weighted-average diluted shares
5,834,858
6,156,699
5,858,330
6,233,430
Basic earnings per share
2.34
1.67
5.43
3.76
Diluted earnings per share
2.33
1.66
5.39
3.74
Potentially dilutive securities, whose effect would have been antidilutive, were not significant for the three- and
six-month periods ended March 28, 2015 and the three- and six-month periods ended March 29, 2014. The Company excluded these securities from the computation of diluted earnings per share.
Table of Contents
Note 2 Financial Instruments
Cash, Cash Equivalents and Marketable Securities
The following tables show the Company s cash and available-for-sale
securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category recorded as cash and cash equivalents or short- or long-term marketable securities as of March 28, 2015 and
September 27, 2014 (in millions):
March 28, 2015
Adjusted
Cost
Unrealized
Gains
Unrealized
Losses
Fair
Value
Cash and
Cash
Equivalents
Short-Term
Marketable
Securities
Long-Term
Marketable
Securities
Cash
9,879
9,879
9,879
Level 1 (1):
Money market funds
1,457
1,457
1,457
Mutual funds
2,384
(126
2,258
2,258
Subtotal
3,841
(126
3,715
1,457
2,258
Level 2 (2):
U.S. Treasury securities
42,854
145
(12
42,987
1,791
41,196
U.S. agency securities
6,901
11
(2
6,910
585
1,056
5,269
Non-U.S. government securities
7,114
86
(80
7,120
41
271
6,808
Certificates of deposit and time deposits
3,473
3,473
1,163
1,252
1,058
Commercial paper
2,956
2,956
1,364
1,592
Corporate securities
100,658
427
(370
100,715
10,325
90,390
Municipal securities
942
(1
946
24
922
Mortgage- and asset-backed securities
14,782
75
(19
14,838
38
14,800
Subtotal
179,680
749
(484
179,945
3,153
16,349
160,443
Total
193,400
749
(610
193,539
14,489
18,607
160,443
September 27, 2014
Adjusted
Cost
Unrealized
Gains
Unrealized
Losses
Fair
Value
Cash and
Cash
Equivalents
Short-Term
Marketable
Securities
Long-Term
Marketable
Securities
Cash
10,232
10,232
10,232
Level 1 (1):
Money market funds
1,546
1,546
1,546
Mutual funds
2,531
(132
2,400
2,400
Subtotal
4,077
(132
3,946
1,546
2,400
Level 2 (2):
U.S. Treasury securities
23,140
15
(9
23,146
12
607
22,527
U.S. agency securities
7,373
(11
7,365
652
157
6,556
Non-U.S. government securities
6,925
69
(69
6,925
204
6,721
Certificates of deposit and time deposits
3,832
3,832
1,230
1,233
1,369
Commercial paper
475
475
166
309
Corporate securities
85,431
296
(241
85,486
6,298
79,182
Municipal securities
940
948
948
Mortgage- and asset-backed securities
12,907
26
(49
12,884
25
12,859
Subtotal
141,023
417
(379
141,061
2,066
8,833
130,162
Total
155,332
418
(511
155,239
13,844
11,233
130,162
(1)
The fair value of Level 1 securities is estimated based on quoted prices in active markets for identical assets or liabilities.
(2)
The fair value of Level 2 securities is estimated based on observable inputs other than quoted prices in active markets for identical assets and liabilities,
quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Table of Contents
The Company may sell certain of its marketable securities prior to their stated maturities for
strategic reasons including, but not limited to, anticipation of credit deterioration and duration management. The net realized gains or losses recognized by the Company related to such sales were not significant during the three- and six-month
periods ended March 28, 2015 and March 29, 2014. The maturities of the Company s long-term marketable securities generally range from one to five years.
As of March 28, 2015 and September 27, 2014, gross unrealized losses related to individual securities that had been in a continuous loss
position for 12 months or longer were not significant.
During the three- and six-month periods ended March 28, 2015 and March 29, 2014,
the Company did not recognize any significant impairment charges. As of March 28, 2015, the Company considers the declines in market value of its marketable securities investment portfolio to be temporary in nature and does not consider any of
its investments other-than-temporarily impaired. The Company typically invests in highly-rated securities, and its investment policy generally limits the amount of credit exposure to any one issuer. The policy generally requires investments to be
investment grade, with the primary objective of minimizing the potential risk of principal loss. Fair values were determined for each individual security in the investment portfolio. When evaluating an investment for other-than-temporary impairment
the Company reviews factors such as the length of time and extent to which fair value has been below its cost basis, the financial condition of the issuer and any changes thereto, changes in market interest rates and the Company s intent to
sell, or whether it is more likely than not it will be required to sell the investment before recovery of the investment s cost basis.
Derivative Financial
Instruments
The Company uses derivatives to partially offset its business exposure to foreign currency and interest rate risk on expected future
cash flows, on net investments in certain foreign subsidiaries and on certain existing assets and liabilities. However, the Company may choose not to hedge certain exposures for a variety of reasons including, but not limited to, accounting
considerations and the prohibitive economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign currency exchange or interest rates.
To help protect gross margins from fluctuations in foreign currency exchange rates, certain of the Company s subsidiaries whose functional
currency is the U.S. dollar may hedge a portion of forecasted foreign currency revenue, and subsidiaries whose functional currency is not the U.S. dollar and who sell in local currencies may hedge a portion of forecasted inventory purchases not
denominated in the subsidiaries functional currencies. The Company may enter into forward contracts, option contracts or other instruments to manage this risk and may designate these instruments as cash flow hedges. The Company typically
hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases, typically for up to 12 months.
To help
protect the net investment in a foreign operation from adverse changes in foreign currency exchange rates, the Company may enter into foreign currency forward and option contracts to offset the changes in the carrying amounts of these investments
due to fluctuations in foreign currency exchange rates. The Company designates these instruments as net investment hedges.
The Company may also
enter into non-designated foreign currency contracts to partially offset the foreign currency exchange gains and losses generated by the re-measurement of certain assets and liabilities denominated in non-functional currencies.
The Company may enter into interest rate swaps, options, or other instruments to manage interest rate risk. These instruments may offset a portion of
changes in income or expense, or changes in fair value of the Company s long-term debt or investments. The Company designates these instruments as either cash flow or fair value hedges. The Company s hedged interest rate transactions as of
March 28, 2015 are expected to be recognized within 12 years.
Cash Flow Hedges
The effective portions of cash flow hedges are recorded in accumulated other comprehensive income ( AOCI ) until the hedged item is recognized
in earnings. Deferred gains and losses associated with cash flow hedges of foreign currency revenue are recognized as a component of net sales in the same period as the related revenue is recognized, and deferred gains and losses related to cash
flow hedges of inventory purchases are recognized as a component of cost of sales in the same period as the related costs are recognized. Deferred gains and losses associated with cash flow hedges of interest income or expense are recognized in
other income/(expense), net in the same period as the related income or expense is recognized.
The ineffective portions and amounts excluded from
the effectiveness testing of cash flow hedges are recognized in other income/(expense), net. These amounts were not significant during the three- and six-month periods ended March 28, 2015 and March 29, 2014.